Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 491-492

  Devecioglu, Omer ^a   Anak, Sema ^a   Atay, Didem ^b,c   Aktan, Pinar ^a   Devecioglu, Esra ^a   Ozalp, Beril ^a   Saribeyoglu, Ebru ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

ALL; Familial or secondary HLH; Viral infection

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CHOLESTEROL; CYCLOSPORIN A; DEFIBROTIDE; FERRITIN; FIBRINOGEN; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RIBAVIRIN; TRIACYLGLYCEROL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; FEBRILE NEUTROPENIA; FERRITIN BLOOD LEVEL; FEVER; FIBRINOGEN BLOOD LEVEL; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INFANT; MAINTENANCE THERAPY; MALE; PANCYTOPENIA; PARVOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TOXOPLASMA GONDII; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VEIN OCCLUSION; VIRUS INFECTION;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 67651212185     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22064     Document Type: Article

References (10)

1. Henter J, Ehrnst A, Andersson J, et al. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993;82:369-372. (Pubitemid 23142852)
2. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program 2005;82-88.
3. Lacz NL. Lymphohistiocytosis, e-medicine article, 2006.
4. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.
5. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-131. (Pubitemid 44958267)
6. Arico M, Danesino C, Pende D, et al. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114:761-769. Review.
7. zurStadt U, Beutel K, Kolberg S, et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: Molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 2006;27:62-68.
8. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-131. (Pubitemid 44958267)
9. Imashuku S, Teramura T, Morimoto A, et al. Recent developments in the management of haemophagocytic lymphohistiocytosis. Expert Opin Pharmacother 2001;2:1437-1448. (Pubitemid 32827414)
10. Menasche G, Feldmann J, Fischer A, et al. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 2005;203:165-179. (Pubitemid 40179701)